77°
A civil lawsuit alleges that Source One Pharmacy Services LLC -- which operates as a pharmacy that is not open for business to the general public -- improperly documented and distributed drugs including opioids, Acting United States Attorney Jennifer Arbittier Williams said.
The complaint further alleges that Source One distributed some drugs to locations where the recipients were not authorized to receive them and that a DEA audit revealed pills were missing from Source One’s records for seven different drugs, Williams said.
Source One agreed to resolve its civil liability by paying $225,000 in civil penalties under the Controlled Substances Act and would be subject to several heightened accountability and monitoring measures for three years, including the requirement that Source One report its dispensing to the DEA, Williams said.
“Pharmacies that handle dangerous controlled substances like opioids must be held to the highest standards in order to ensure that the drugs are properly monitored and do not end up in the wrong hands,” Williams said.
“This civil suit and consent judgment send a strong message to the community that, if a pharmacy violates these important standards, laws, and regulations, it will face serious consequences.”
“Source One Pharmacy is alleged to have improperly dispensed opioids and failing to maintain an accurate inventory of their controlled substances,” said Jonathan A. Wilson, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Philadelphia Field Division.
“Civil penalties such as these are an effective means to ensure the proper safeguarding of controlled substances and compliance with the Controlled Substances Act.”
The case was investigated by the Philadelphia Field Division of the Drug Enforcement Administration.
The civil investigation, litigation, and resolution are being handled by Assistant United States Attorneys Scott W. Reid and Anthony D. Scicchitano.
Click here to follow Daily Voice Bristol and receive free news updates.
